US Stock MarketDetailed Quotes

NUTX Nutex Health

Watchlist
  • 66.0600
  • -1.3000-1.93%
Close Feb 14 16:00 ET
  • 66.0600
  • 0.00000.00%
Post 20:01 ET
359.17MMarket Cap-7.20P/E (TTM)

About Nutex Health Company

Nutex Health, Inc. is a technology-enabled healthcare service. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals and hospital outpatient departments providing comprehensive and high-quality 24/7 care. The Population Health Division establishes and operates independent physician associations and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real State Division includes owning land and hospital buildings which are leased to the hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Company Profile

SymbolNUTX
Company NameNutex Health
Listing DateApr 4, 2022
Founded2011
CEODr. Thomas T. Vo, M.B.A.,M.D.
MarketNASDAQ
Employees1030
Fiscal Year Ends12-31
Address6030 South Rice Avenue,Suite C
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77081
Phone1-713-660-0557

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Thomas T. Vo, M.B.A.,M.D.
  • Chairman of the Board and Chief Executive Officer
  • 1.01M
  • Dr. Michael L. Chang, M.D.
  • Chief Medical Officer
  • --
  • Elisa Luqman, Esq.,M.B.A.
  • Chief Legal Officer, SEC
  • --
  • Jon C. Bates, C.P.A.,M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 453.71K
  • Joshua DeTillio
  • Chief Operating Officer
  • --
  • Pamela Montgomery, R.N.
  • Chief Legal Officer, Healthcare and Secretary
  • --
  • Dr. Warren Hosseinion, M.D.
  • Director and President
  • 734.39K
  • Dr. Kelvin Spears, M.D.
  • Director
  • --
  • Mitchell Creem
  • Independent Director
  • 144.38K
  • Cheryl Grenas, R.N.
  • Independent Director
  • 131.25K
  • Michael L. Reed
  • Independent Director
  • 144.38K
  • Scott J. Saunders
  • Independent Director
  • --

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More